Lilly Endowment Inc sold $279.3M of Eli Lilly and (LLY)

Executed Nov 11 2025, disclosed Nov 12 2025, 1 day later.

Value, as filed

$279.3M

283,131 sh across 27 lots

Executed

Nov 11 2025

the trade date, as filed

Disclosed

Nov 12 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

LI Lilly Endowment Inc Other profile →

Lilly Endowment Inc (Other) filed 19 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 19 sales, 1 filed past the two-business-day deadline), most often in Eli Lilly and Company (LLY). The largest single filing was $75.9B of LLY (178,295 sh across 4 lots, as filed), executed Nov 14 2025.

The name

LLY

Eli Lilly and Company LLY · Healthcare · 118 filings in 24 months ticker →

Healthcare · Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Jap…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Lilly Endowment Inc in LLY

LLYSALE Eli Lilly and Company $15.8M
15,828 sh across 2 lots
Exec May 6
Filed May 7 · 5:30 PM ET LLYSALE Eli Lilly and Company $322.4M
292,148 sh across 30 lots
Exec Jan 7
Filed Jan 8 · 5:30 PM ET LLYSALE Eli Lilly and Company $1.5M
1,390 sh × $1,085.01
Exec Jan 5
Filed Jan 6 · 5:30 PM ET LLYSALE Eli Lilly and Company $3.9M
3,593 sh × $1,085.04
Exec Dec 29 2025
Filed Dec 30 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company $2.9M
2,629 sh × $1,085.17
Exec Dec 24 2025
Filed Dec 29 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company $260K
240 sh × $1,085.04
Exec Dec 23 2025
Filed Dec 29 2025 · 5:30 PM ET † LLYSALE Eli Lilly and Company $161.1M
147,061 sh across 30 lots
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company $17.3M
15,632 sh across 3 lots
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET